NCT06588530 - PFAS Exposure and Immune Response to Vaccination in Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

January 8, 2025

Study Completion Date

January 8, 2025

Conditions

Innate Inflammatory ResponseVaccinationDiphtheriaTetanusEnvironmental ExposureVaccineAntibodiesAdultImmunityPollution; Exposure

Interventions

BIOLOGICAL

TENIVAC

TENIVAC (Tetanus and Diphtheria Toxoids Adsorbed) is an active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older.

Trial Locations (1)

08066

EOHSI Paulsboro Office, Paulsboro

All Listed Sponsors

lead

Rutgers, The State University of New Jersey

OTHER